MedPath

Metabolism Prescription Combined with Metformin in the Intervention of Type 2 Diabetes Mellitus Combined with Obesity: a Multicenter Randomized Controlled Double-Blind Clinical Study

Phase 1
Conditions
Type 2 Diabetes Mellitus combined with Obesity
Registration Number
ITMCTR2000003636
Lead Sponsor
onghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Between 18-65 years old; meet the diagnostic criteria for type 2 diabetes combined with obesity; willing to cooperate with this trial treatment plan and sign an informed consent form.

Exclusion Criteria

Pregnant or lactating women; those who are allergic to acupoint embedding therapy; those who have serious complications such as heart, liver, kidney, and brain; and those with other serious primary diseases; and those with mental illness.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
weight;Glycated hemoglobin;
Secondary Outcome Measures
NameTimeMethod
C Peptides;Blood lipids;Inflammatory factors;MRI measurement of subcutaneous and visceral fat content in the upper abdomen;insulin;Fasting blood glucose;
© Copyright 2025. All Rights Reserved by MedPath